1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow SARS-CoV-2 Acute Respiratory Disease: new trials by email Literature Review of SARS-CoV-2 Acute Respiratory Disease trials Research Report on SARS-CoV-2 Acute Respiratory Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase III Trial to Assess the Safety and Immunogenicity of a HIPRA's Candidate Booster Vaccination Against COVID-19. COVID-19 Vaccine 40 ug/dose - COVID-19, SARS-CoV-2 Acute Respiratory Disease | Phase 3 | Completed | Hipra Scientific, S.L.U | 2646 | 2022-02-03 | 2023-03-15 |
COVID-19 (1)
Coronaviridae Infections (1) · Coronavirus Infections (1) · Infections (1) · Lung Diseases (1) · Nidovirales Infections (1) · Pneumonia (1) · Pneumonia, Viral (1) · RNA Virus Infections (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Virus Diseases (1)
Italy (1) · Spain (1)